Comment

Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.

Crit. Care Med. 2006 Sep 1;34(9):2310-6.
Review

Recombinant human erythropoietin use in intensive care.

Ann Pharmacother. 2002 Jun 1;36(6):1068-74.
Review

Alternatives to blood product transfusion in the critically ill: erythropoietin.

Crit. Care Med. 2006 May 1;34(5 Suppl):S160-9.